Gabelli Healthcare & WellnessRx Trust Increases Quarterly Distribution 18% to $0.20 from $0.17 Annualized Distribution to $0.80 from $0.68 Per Share

The annualized payout rises to $0.80 per share, while estimated 2026 distributions include a return-of-capital component.

Rhea-AI Summary

Gabelli Healthcare & WellnessRx Trust (NYSE: GRX) raised its quarterly distribution to $0.20 per share, payable December 18, 2026.

The increase from $0.17 is 18%, bringing the annualized distribution to $0.80 from $0.68 per share. Common shareholders of record on December 11, 2026 qualify for the payment. Based on currently available accounting records, each distribution paid in 2026 would include approximately 11% net investment income, 52% net capital gains and 37% return of capital on a book basis. These estimates are not tax-reporting information; final sources will be determined after year-end and may differ.

1 point · 0 major

PositiveiHow this balance works

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance worksHow Sentiment works

0 major · 1 point

Hollow bars mark forward-looking points. How the balance works

Positive

• Moderate pointQuarterly distribution rises 18% to $0.20 from $0.17; annualized payout increases to $0.80 from $0.68.

Negative

• Minor point. Forward-looking: it has not happened yet and may not happen.Approximately 37% return of capital is estimated for each 2026 distribution on a book basis, not for tax reporting.

News Explained

The quarterly distribution policy is not a fixed commitment: the Board may modify or terminate it at any time; each quarter it reviews income, realized gains and available capital, and the Fund may make an additional December adjustment to meet regulated-investment-company minimums.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

RYE, N.Y., Nov. 11, 2026 (GLOBE NEWSWIRE) -- The Board of Trustees of The Gabelli Healthcare & Wellness^Rx Trust (NYSE: GRX) (the “Fund”) approved an increase in the annualized distribution to $0.80 per share, which will be paid $0.20 per share quarterly, commencing with the quarterly distribution payable on December 18, 2026 to common shareholders of record on December 11, 2026.

The Fund intends to pay a quarterly distribution determined by the Board of Trustees. In addition to the quarterly distributions, and in accordance with the minimum distribution requirements of the Internal Revenue Code for regulated investment companies, the Fund may pay an adjusting distribution in December which includes any additional income and net realized capital gains in excess of the quarterly distributions for that year.

Each quarter, the Board of Trustees reviews the amount of any potential distribution and the income, realized capital gain, or capital available. The Board of Trustees will continue to monitor the Fund’s distribution level, taking into consideration the Fund’s net asset value and the current financial market environment. The Fund’s distribution policy is subject to modification or termination by the Board of Trustees at any time, and there can be no guarantee that the policy will continue. The distribution rate should not be considered the dividend yield or total return on an investment in the Fund.

All or part of the distribution may be treated as long-term capital gain or qualified dividend income (or a combination of both) for individuals, each subject up to the maximum federal income tax rate for long term capital gains, which is currently 20% in taxable accounts for individuals (or less depending on an individual’s tax bracket). In addition, certain U.S. shareholders who are individuals, estates or trusts and whose income exceeds certain thresholds will be required to pay a 3.8% Medicare surcharge on their "net investment income", which includes dividends received from the Fund and capital gains from the sale or other disposition of shares of the Fund.

If the Fund does not generate earnings (dividends and interest income, less expenses, and realized net capital gain) equal to or in excess of the aggregate distributions paid by the Fund in a given year, then the amount distributed in excess of the Fund’s earnings would be deemed a return of capital. Since this would be considered a return of a portion of a shareholder’s original investment, it is generally not taxable and would be treated as a reduction in the shareholder’s cost basis.

Long-term capital gains, qualified dividend income, investment company taxable income, and return of capital, if any, will be allocated on a pro rata basis to all distributions to common shareholders for the year. Based on the accounting records of the Fund currently available, each of the distributions paid to common shareholders in 2026 would include approximately 11% from net investment income, 52% from net capital gains and 37% would be deemed a return of capital on a book basis. This does not represent information for tax reporting purposes. The estimated components of each distribution are updated and provided to shareholders of record in a notice accompanying the distribution and are available on our website (www.gabelli.com). The final determination of the sources of all distributions in 2026 will be made after year end and can vary from the quarterly estimates. Shareholders should not draw any conclusions about the Fund’s investment performance from the amount of the current distribution. All individual shareholders with taxable accounts will receive written notification regarding the components and tax treatment for all 2026 distributions in early 2027 via Form 1099-DIV.

Investors should carefully consider the investment objectives, risks, charges, and expenses of the Fund before investing. For more information regarding the Fund’s distribution policy and other information about the Fund, call:

Bethany Uhlein
(914) 921-5546

About The Gabelli Healthcare & Wellness^Rx Trust

The Gabelli Healthcare & Wellness^Rx Trust is a diversified, closed-end management investment company with $237 million in total net assets whose primary investment objective is long-term growth of capital. The Fund is managed by Gabelli Funds, LLC, a subsidiary of GAMCO Investors, Inc. (OTCQX: GAMI).

NYSE: GRX
CUSIP – 36246K103

THE GABELLI HEALTHCARE & WELLNESSRx TRUST
Investor Relations Contact:
Bethany Uhlein
914.921.5546
buhlein@gabelli.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will GRX pay its increased quarterly distribution, and who qualifies?

GRX will pay $0.20 per common share on December 18, 2026, to shareholders of record on December 11, 2026. The quarterly amount increases from $0.17, with the annualized distribution rising to $0.80 from $0.68 per share.

Could Gabelli Healthcare & WellnessRx Trust pay an additional December distribution?

The Fund may pay an adjusting distribution in December that includes additional income and net realized capital gains exceeding that year’s quarterly distributions, in accordance with minimum distribution requirements for regulated investment companies.

When will GRX shareholders receive final tax information for 2026 distributions?

Individual shareholders with taxable accounts will receive Form 1099-DIV in early 2027 detailing the components and tax treatment of all 2026 distributions. Return of capital generally reduces a shareholder’s cost basis and is generally not taxable.